首页> Cardiology research and practice> Impact of rosuvastatin treatment on HDL-induced PKC-β II and eNOS phosphorylation in endothelial cells and its relation to flow-mediated dilatation in patients with chronic heart failure

Impact of rosuvastatin treatment on HDL-induced PKC-β II and eNOS phosphorylation in endothelial cells and its relation to flow-mediated dilatation in patients with chronic heart failure

导出原文传递

翻译打印收藏纠错

第一作者： Winzer

作者： Winzer ^[1] ; E.B. ; Gaida ; P. ; H?llriegel ; R. ; Fischer ; T. ; Linke ; A. ; Schuler ; G. ; Adams ; V. ; Erbs ; S.

作者单位： Leipzig Heart Center, Department of Cardiology, Leipzig University, Leipzig, Germany ^[1]

发布时间 2018-03-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Cardiology research and practice

2016年2016卷

4826102-4826102页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

点击下载本期目录封面

Cardiology research and practice

2016年2016卷

4826102-4826102页

检索历史清除

Impact of rosuvastatin treatment on HDL-induced PKC-β II and eNOS phosphorylation in endothelial cells and its relation to flow-mediated dilatation in patients with chronic heart failure

Cardiology research and practice

相似文献

同项目论文

Cardiology research and practice

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Impact of rosuvastatin treatment on HDL-induced PKC-β II and eNOS phosphorylation in endothelial cells and its relation to flow-mediated dilatation in patients with chronic heart failure

Cardiology research and practice

相似文献

同项目论文

Cardiology research and practice

相关期刊

检索历史清除